ClinVar Miner

Submissions for variant NM_012330.4(KAT6B):c.5389C>T (p.Arg1797Ter)

dbSNP: rs199470484
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001380964 SCV001579196 pathogenic Genitopatellar syndrome 2020-04-26 criteria provided, single submitter clinical testing This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the KAT6B gene (p.Arg1797*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 277 amino acids of the KAT6B protein. For these reasons, this variant has been classified as Pathogenic. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has been observed in individual(s) with Say-Barber-Biesecker-Young-Simpson syndrome (PMID: 22077973, 23436491). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 50357).
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV004786317 SCV005400435 pathogenic KAT6B-related multiple congenital anomalies syndrome 2024-10-09 criteria provided, single submitter clinical testing Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Loss of function and gain of function are likely mechanisms of disease in this gene and are associated with Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) (MIM#603736) and genitopatellar syndrome (GPS) (MIM#606170), respectively; these two conditions are also referred to as KAT6B-related multiple congenital anomalies syndrome (MONDO:0036042) which also include individuals with intermediate phenotypes consisting of SBBYSS and GPS features. NMD-predicted variants have a loss of function mechanism, and are associated with SBBYSS. Truncating variants (PTVs) found in the last exon have been reported for both conditions, and are likely to have both a loss- and gain of function effect. PTVs found in the proximal end of the final exon have been reported in patients with GPS, while PTVs in the terminal end of the final exon have SBBYSS (PMIDs: 22715153, 32424177). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0205 - Variant is predicted to result in a truncated protein (premature termination codon is NOT located at least 54 nucleotides upstream of the final exon-exon junction) with less than 1/3 of the protein sequence affected. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0701 - Other protein truncating variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. More than five downstream truncating variants have been identified in individuals with SSBYSS or with an intermediate phenotype overlapping both SBBYSS and GPS (PMID: 32424177). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported as de novo in at least three individuals with SBBYSS or an intermediate phenotype with overlapping features of SBBYSS and GPS (PMIDs: 22077973, 23436491, 28857140). It has also been classified as pathogenic by a clinical laboratory in ClinVar. (SP) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed) (by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign
OMIM RCV000043512 SCV000067382 pathogenic Blepharophimosis - intellectual disability syndrome, SBBYS type 2013-04-01 no assertion criteria provided literature only
Lee Lab(KAT6B), Baylor College of Medicine RCV000128660 SCV000172300 not provided not provided no assertion provided not provided
GeneReviews RCV000043512 SCV001190853 not provided Blepharophimosis - intellectual disability syndrome, SBBYS type no assertion provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.